Abstract
In our cross-sectional study, we assessed the feasibility of using the ACR LI-RADS screening and diagnostic pathway for Hepatocellular Carcinoma (HCC) in a low-middle-income setting. HCC develops in a well-defined high-risk population, but many countries in this income category lack HCC screening and surveillance guidelines. The ACR’s practical approach through LI-RADS provides a valuable solution. Our study showed that 5.66% of patients had positive ultrasound findings, and significant lesions were detected on multiphasic CT scans. Out of these, 1.89% were diagnosed with definite HCC (LR-5 lesions). We conclude that HCC screening and diagnosis using ACR LI-RADS algorithms are feasible in such settings. However, success hinges on knowledge, skills, and technical capacity building, and it is vital to consider the downstream effects of the screening and surveillance program during the design process.
Summary HCC screening and diagnosis using the ACR LI-RADS algorithms are feasible in low-middle-income settings, making it applicable and recommendable for even lower-income countries. However, successful implementation requires a focus on knowledge, skills, and technical capacity building.
Key points
Eligible patients for hepatocellular carcinoma screening and surveillance programs are easily identifiable in low middle income countries.
American College of Radiology’s Liver Imaging Reporting and Data Systems algorithm provides a practical approach to hepatocellular carcinoma screening and surveillance.
With proper knowledge, skills, and technical capacity, this algorithm is feasible in a low middle income setting, factoring tiered levels of care and referral systems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
For this research was received from KNH Research Program They did not play a role in the conducting of the research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research proposal was approved by Kenyatta National Hospital- University of Nairobi Ethics Research and Committee, reference number P1029/12/2019.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
none
Abbreviations
- HCC
- hepatocellular carcinoma
- US
- ultrasound
- ACR
- American College of Radiology
- LI-RADS
- Liver Imaging and Reporting Data Systems
- CT
- Computed Tomography
- GLOBOCAN
- Global Cancer Observatory
- MDT
- multi-disciplinary team
- AASLD
- American Association for the Study of Liver Diseases
- NCCN
- National Comprehensive Cancer Network
- EASL
- European Association for the Study of Liver
- JSH
- Japanese Society of Hepatology
- CEUS
- contrast enhanced ultrasound
- MRI
- magnetic resonance imaging
- HBV
- hepatitis B virus
- HIV
- human immunodeficiency virus
- KNH
- Kenyatta National Hospital
- UON
- University of Nairobi
- ECM
- Ephranzia Chao Malindi
- TMM
- Timothy Musila Mutala
- SOA
- Stephen Onyango Ayo
- RKO
- Roseline Kerubo Ogaro
